CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Görünümler
• 07/14/23
0
0
gömmek
administrator
Aboneler
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar